Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients
- Study Title
- Comparative Bioavailability of Myfenaxֲ® and CellCeptֲ® in Kidney Transplant Patients
- Teva Identifier
- 116B8 | 2009-010562-31
- ClinicalTrials.gov Identifier
- NCT00991510
- Study Status
- Terminated
- Trial Condition(s)
- Stable Renal Transplant Recipients
- Interventions
- Drug: mycophenolate mofetil (Myfenax) | Drug: mycophenolate mofetil (Cellcept)
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 08/01/2009 - 10/01/2010
- Phase
- Phase 4
